PMC:7696151 / 44691-44852 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1255","span":{"begin":11,"end":14},"obj":"Chemical"},{"id":"1256","span":{"begin":91,"end":104},"obj":"Chemical"}],"attributes":[{"id":"A1255","pred":"tao:has_database_id","subj":"1255","obj":"MESH:D006886"},{"id":"A1256","pred":"tao:has_database_id","subj":"1256","obj":"MESH:D012460"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"rated that HCQ showed no significant differences among overall clinical effects respect to sulfasalazine, but presented a later onset. In the first study, patien"}